Thyroxine Replacement in Organ Donors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

May 31, 2009

Study Completion Date

October 31, 2010

Conditions
Brain Death
Interventions
DRUG

L-thryoxine

2 mcg/kg iv or 2 mcg/kg po at time of enrollment

DRUG

iv thryoxine

thyroxine 2 mcg/kg iv

Trial Locations (1)

N6A5A5

London Health Sciences Centre-UC, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT00238030 - Thyroxine Replacement in Organ Donors | Biotech Hunter | Biotech Hunter